abstract |
The present invention relates to new uses of the protein sequence (INSP052), identified in this application as a cell surface recognition molecule containing immunoglobulin domains, for the purpose of diagnosing, preventing and treating diseases, in particular diseases associated with over-expression and / or secretion of cytokines. |